当前位置: 首页 > 期刊 > 《医学新知杂志》 > 20113
编号:13771250
隐匿性乳腺癌10例诊治分析(2)
http://www.100md.com 2011年3月1日 《医学新知·综合版》 20113
     [3]Kenery MM, RiveraDE, Terz JJ, et al. Occult primary adenocarcinoma with axillary metastases[J]. Am J Surg, 1986, 152(1):43-47.

    [4]牛昀,范宇,傅西林.隐性乳腺癌的全乳癌的全乳腺连续大切片检查[J].中华肿瘤杂志,1995, 17(4); 298-300.

    [5]Owen HW, DockertyMB, Gray HK. Occult carcinoma of the breast [J]. Surg Gynecol Obstet, 1954, 98(3):302-308.

    [6]Henry-Tillman RS, Harms SE, Westbrook KC, et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy[J]. Am J Surg,1999, 178(6): 496-500.

    [7]Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary m alignancy[J]. Radiology, 1999, 212(2): 543-549.

    [8] Olson JA Jr, Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer[J]. Ann Surg Oncol, 2000, 7(6): 411-415.

    [9]Stomper PC, Waddell BE, edge SB, et al. breast MRI in the evaluation of patients with occult primary breast carcinoma[J]. Breast J, 1999, 5(4):230234.

    [10]牛昀,傅西林,牛瑞芳,等.抗人乳腺癌單抗M4G3在隐性乳腺癌诊断中的应用.中华实验外科杂志,2003,20:654-685.

    [11]Patel J, Nemoto T, Rosner D, et al. Axillary lymph node metastasis from an occult breast cancer[J]. Cancer, 1981,47(12):2923-2927.

    [12]Vlastos G, Jean ME, Mirza AN, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases[J]. Ann Surg Oncol 2001,8(5):425-431., 百拇医药(吴威 赵永华)
上一页1 2